We are live on ! Find out more
OCM

Orser Capital Management Portfolio holdings

AUM $202M
1-Year Est. Return 32.65%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+32.65%
3 Year Est. Return
+122.2%
5 Year Est. Return
+162.36%
10 Year Est. Return
AUM
$103M
AUM Growth
+$17.8M
Cap. Flow
+$12.1M
Cap. Flow %
11.77%
Top 10 Hldgs %
37.05%
Holding
85
New
16
Increased
37
Reduced
17
Closed
3

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$2.25M
2
PXD
Pioneer Natural Resource Co.
PXD
+$202K
3
DHR icon
Danaher
DHR
+$140K
4
CVX icon
Chevron
CVX
+$87.5K
5
BA icon
Boeing
BA
+$70.8K

Sector Composition

Rank Sector Weight
1 Technology 23.55%
2 Healthcare 14.85%
3 Consumer Staples 7.94%
4 Consumer Discretionary 7.5%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
26
Nike
NKE
$61.9B
$1.37M 1.33%
13,633
+80
+0.6% +$7.54K
PCTY icon
27
Paylocity
PCTY
$7.98B
$1.37M 1.33%
11,460
-30
-0.3% -$3.29K
ZTS icon
28
Zoetis
ZTS
$30B
$1.37M 1.32%
10,330
-155
-1% -$19.3K
CL icon
29
Colgate-Palmolive
CL
$74.4B
$1.26M 1.22%
18,300
+35
+0.2% +$2.39K
VTV icon
30
Vanguard Morningstar Value ETF
VTV
$191B
$1.24M 1.2%
+10,380
New +$1.2M
DHR icon
31
Danaher
DHR
$144B
$1.21M 1.18%
8,948
-1,108
-11% -$140K
VIG icon
32
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.21M 1.17%
9,705
+230
+2% +$27.8K
MCD icon
33
McDonald's
MCD
$195B
$1.19M 1.15%
6,020
+634
+12% +$126K
EPD icon
34
Enterprise Products Partners
EPD
$81.7B
$1.18M 1.15%
42,355
+5,514
+15% +$149K
XBI icon
35
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$1.16M 1.12%
12,234
+8,580
+235% +$742K
INTC icon
36
Intel
INTC
$513B
$1.11M 1.08%
18,697
+12,297
+192% +$688K
HON icon
37
Honeywell
HON
$78B
$1.03M 1%
6,213
+160
+3% +$26.2K
GSY icon
38
Invesco Ultra Short Duration ETF
GSY
$3.9B
$1M 0.97%
19,900
VUG icon
39
Vanguard Morningstar Growth ETF
VUG
$231B
$804K 0.78%
26,550
+930
+4% +$26.9K
RVTY icon
40
Revvity
RVTY
$12.8B
$780K 0.76%
8,070
UNP icon
41
Union Pacific
UNP
$174B
$702K 0.68%
3,896
+100
+3% +$17.1K
WM icon
42
Waste Management
WM
$91B
$692K 0.67%
+6,080
New +$687K
VOO icon
43
Vanguard S&P 500 ETF
VOO
$1.01T
$684K 0.66%
2,320
ABBV icon
44
AbbVie
ABBV
$435B
$679K 0.66%
+7,671
New +$637K
CASY icon
45
Casey's General Stores
CASY
$30.9B
$673K 0.65%
4,250
+360
+9% +$59.6K
XLV icon
46
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$611K 0.59%
6,011
-1
-0% -$96
ORCL icon
47
Oracle
ORCL
$423B
$509K 0.49%
9,654
-210
-2% -$11.6K
OKE icon
48
Oneok
OKE
$54.5B
$508K 0.49%
6,732
+1,182
+21% +$84.5K
IVV icon
49
iShares Core S&P 500 ETF
IVV
$902B
$484K 0.47%
1,500
XLY icon
50
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$463K 0.45%
7,400
-2
-0% -$122

Similar funds

Orser Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Orser Capital Management held 85 positions worth $103M, up 21% from $85.3M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Orser Capital Management deployed $12.1M of net new capital in Q4 2019, opening 16 new positions and adding to 37 existing holdings. Its largest new stake was Edwards Lifesciences: 42,183 shares worth $3.27M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Danaher, an estimated $140K trimmed.

  • Orser Capital Management's largest Q4 2019 buy was Edwards Lifesciences: 42,183 shares worth $3.27M.
  • Orser Capital Management added most to State Street SPDR S&P Biotech ETF in Q4 2019, an estimated $742K increase.
  • Orser Capital Management's biggest Q4 2019 reduction was Danaher, cutting an estimated $140K.
  • Orser Capital Management fully exited Elbit Systems in Q4 2019, selling an estimated $2.25M.
  • Orser Capital Management's ten largest holdings make up 37% of its $103M portfolio in Q4 2019.
  • Orser Capital Management opened 16 new positions and closed 3 in Q4 2019.
  • Orser Capital Management's portfolio value rose 21% quarter-over-quarter to $103M.

Based on Orser Capital Management's 13F filing for Q4 2019, filed 17 Jan 2020.